Table 2.
Significant bacterial isolates from specimens submitted during work up for suspected HAI
| Organism | Sample type | Syndrome | Sensitivity to 3GC | Empirical Rx | Empirical Rx changed |
|---|---|---|---|---|---|
| Acinetobacter baumanii | ETT | VAP | R | Imi/mero | No |
| Acinetobacter baumanii | B/C | VAP | R | Ceftriaxone | Yes |
| Coliforma | B/C | Gastro | S | Imi/mero | No |
| Enterobacter cloacae | B/C | Primary BSI | R | Imi/mero | No |
| Enterobacter cloacae | B/C | Gastro | S | Imi/mero | No |
| Enterobacter cloacae | B/C | Line | R | Imi/mero | No |
| Escherichia coli | Urine | UTI | R | Imi/mero | No |
| Escherichia coli | B/C & urine | UTI | R | Imi/mero | No |
| Escherichia coli Pseudomonas aeruginosa | B/C | NEC | S Int-R |
Imi/mero | No |
| Klebsiella pneumoniae | B/C | HAP | R | Imi/mero | No |
| Klebsiella pneumoniae | B/C | VAP | R | Imi/mero | No |
| Moraxella catarrhalis | B/C | HAP | S | Ceftriaxone | No |
| Staphylococcus aureus (MRSA) | B/C | SSTI | R | Imi/mero | Yes |
| Stenotrophomonas maltophilia Enterococcus species | B/C | NEC | Int-R Int-R |
Imi/mero | Yes |
| Streptococcus pyogenes | B/C | SSTI | S | Cloxacillin | Yes |
| Yeast | B/C | Gastro | Int-R | Ceftriaxone | Yes |
3GC third generation cephalosporin, B/C blood culture, BSI blood stream infection, ETT endotracheal tube secretions, Gastro gastroenteritis, HAP hospital-acquired pneumonia, Imi/mero carbapenem (imipenem or meropenem), Int-R intrinsically resistant, MRSA methicillin resistant Staphylococcus aureus, NEC necrotizing enterocolitis, R resistant, Rx treatment, S sensitive, SSTI skin and soft tissue infection, UTI urinary tract infection, VAP ventilator-associated pneumonia,
aThis coliform could not be identified to a satisfactory level using the biochemistry short set or bioMerieux API kits available at AHC